NDC 51662-1337
Dobutamine 12.5 mg per 1 mL injection, solution, concentrate
On the label: HF Acquisition Co. LLC. DBA HealthFirst. It's repackaged: HF Acquisition Co. LLC. DBA HealthFirst rebottles it from Hospira, Inc.'s NDC 0409-2344.
Where the pills inside were made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Hospira, Inc. | Rocky Mount, NC, United States | Makes it, tests it, packages it and labels it | No problems foundFeb 7, 2025 · 11 inspections, 3 with FDA action |
| Hospira, Inc. | McPherson, KS, United States | Tests it | Problems found, fixed voluntarilyJan 17, 2025 · 16 inspections, 2 with FDA action |
Repackaging site
- HF Acquisition Co LLC, Mukilteo, WA, United States · relabels it
Recalls
- May 28, 2025 · Class II · Pfizer Inc.
Discoloration; discolored solution from cracked vials
Lots: Lot KA5023, exp 02/28/2026 - Jan 10, 2014 · Class I · Hospira Inc.
Presence of Particulate Matter: Discolored solution due to a chip in the glass at the neck of the vial, also glass particulate was found within the solution.
Lots: Lot # 27-352-DK; Exp 03/15
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Dobutamine: every company that makes it
- Form
- injection, solution, concentrate, intravenous
- Strength
- 12.5 mg per 1 mL
- Approval
- ANDA ANDA074086
- On the market since
- Nov 26, 2018
- Package NDCs
51662-1337-151662-1337-251662-1337-3- Official label
- DailyMed (National Library of Medicine), updated Feb 19, 2024
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?